Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 29.1B | 29.4B | 25.5B | 26.2B |
| Cost of revenue | 18.1B | 18.3B | 15.5B | 15.7B |
| Gross profit | 10.9B | 11.1B | 10.0B | 10.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 3.1B | 3.1B | 2.7B | 3.4B |
| Non operating interest income | ||||
| Income | 218M | 189M | 194M | 158M |
| Expense | 1M | 0 | 0 | 0 |
| Other income expense | — | — | — | — |
| Pretax income | 3.7B | 3.0B | 3.1B | 3.7B |
| Tax provision | 450M | 870M | 1.0B | 1.2B |
| Net income | 3.3B | 2.1B | 2.0B | 2.5B |
| Basic EPS | — | — | — | 29.7 |
| Diluted EPS | — | — | — | 29.7 |
| Basic average shares | — | — | — | 12.7B |
| Diluted average shares | — | — | — | 12.7B |
| EBITDA | 4.6B | 3.9B | 3.8B | 4.2B |
| Net income from continuing op. | 3.7B | 3.0B | 3.1B | 3.7B |
| Minority interests | 15M | -1M | 0 | 0 |
| Preferred stock dividends | 0 | 0 | 0 | 0 |